Found 66 matching trials
Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Hospital Italiano de Buenos Aires
Learn More & Join Trial
Efficacy and Safety of Idelalisib in Combination With Obinutuzumab Compared to Chlorambucil in Combination With Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukemia PHASE3 The primary objective of this study is to evaluate the effects of idelalisi...
Show More Learn More & Join Trial
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma PHASE2 Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2) PHASE3 This open-label, randomized, 3-arm study will evaluate the efficacy and saf...
Show More Location
Multiple Locations
Learn More & Join Trial
A Trial Looking at Ofatumumab for People With Chronic Lymphocytic Leukaemia Who Cannot Have More Intensive Treatment PHASE3 The purpose of this study is to compare ofatumumab \& chlorambucil (O-Chl) ...
Show More Location
Countess of Chester Hospital
Learn More & Join Trial
Open-label Phase 3 BTK Inhibitor Ibrutinib vs Chlorambucil Patients 65 Years or Older With Treatment-naive CLL or SLL PHASE3 A Randomized, Multicenter, Open-label, Phase 3 Study of the Bruton's Tyrosi...
Show More Location
Site Reference ID/Investigator #047
Learn More & Join Trial
A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia. PHASE2 This single arm study will assess the efficacy and safety of MabThera + chl...
Show More Location
Uni Degli Studi Di Bari, Policlinico; Cattedra Di Ematologia,Dipart. Di Medicina Interna E Publica
Learn More & Join Trial
Study to Investigate Idelalisib in Combination With Chemotherapeutic Agents, Immunomodulatory Agents and Anti-CD20 Monoclonal Antibody (mAb) in Participants With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma or Chronic Lymphocytic Leukemia PHASE1 The primary objective of the study is to evaluate the safety of idelalisib ...
Show More Location
Clearview Cancer Institute
Learn More & Join Trial
A Study of Lisaftoclax (APG-2575) Combined With Acalabrutinib Versus Immunochemotherapy for Newly Diagnosed CLL/SLL. PHASE3 This is a global, multicenter, randomized, open-label, Phase III confirmato...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial
Phase II Study of Chlorambucil and Subcutaneous Rituximab in Patients With Extranodal MALT Lymphoma PHASE2 Single arm phase II study of Chlorambucil in combination with subcutaneous ...
Show More Status
Active Not Recruiting
Location
Créteil Hopital Henri Mondor
Learn More & Join Trial